Oragenics’ Dr. James Kelly Joins Medical Board to Advance Concussion Care

Dr. James Kelly, a renowned expert in brain injury research, has been appointed to the Medical Board of The Leigh Steinberg Foundation. With a distinguished career in traumatic brain injury (TBI) care, Dr. Kelly has played a pivotal role in advancing treatments for concussions, particularly for military personnel and athletes. His work at Oragenics, where he serves as Chief Medical Officer, includes leading the development of ONP-002, an innovative intranasal concussion treatment. The foundation, known for its commitment to brain health, welcomes Dr. Kelly’s expertise to further research and improve care for those affected by TBI.

Expressing his enthusiasm, Dr. Kelly emphasized the urgent need for better concussion treatments and the role innovative solutions can play in recovery. Leigh Steinberg, founder of the foundation, praised Dr. Kelly’s contributions, highlighting his leadership in shaping the future of brain injury care. Oragenics’ Interim CEO, Janet Huffman, echoed similar sentiments, noting that his appointment aligns with the company’s mission to revolutionize concussion treatment. As part of the board, Dr. Kelly will collaborate with top researchers and advocates to drive advancements in TBI care, ensuring better outcomes for patients worldwide.